Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors
- 1 December 2007
- journal article
- practice guideline
- Published by Elsevier in Genetics in Medicine
- Vol. 9 (12) , 819-825
- https://doi.org/10.1097/gim.0b013e31815bf9a3
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Breastfeeding During Maternal Antidepressant Treatment With Serotonin Reuptake InhibitorsThe Journal of Clinical Psychiatry, 2004
- Cytochrome P450 Genotyping by Multiplexed Real-Time DNA Sequencing with Pyrosequencing™ TechnologyASSAY and Drug Development Technologies, 2002
- A rare G2061 insertion affecting the open reading frame of CYP2D6 and responsible for the poor metabolizer phenotypePharmacogenetics, 1999
- Characterization of the 16+9 kb and 30+9 kb CYP2D6 Xbal haplotypesPharmacogenetics, 1997
- A novel mutant variant of the CYP2D6 gene (CYP2D617) common in a black African population: association with diminished debrisoquine hydroxylase activityBritish Journal of Clinical Pharmacology, 1996
- Homologous unequal cross-over involving a 2.8 kb direct repeat as a mechanism for the generation of allelic variants of the human cytochrome P450 CYP2D6 geneHuman Molecular Genetics, 1995
- A novel CYP2D6 allele with an abolished splice recognition site associated with the poor metabolizer phenotypePharmacogenetics, 1995
- Cloning and sequencing of a new non-functional CYP2D6 allele: Deletion of T1795 in exon 3 generates a premature stop codonPharmacogenetics, 1994
- Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotypeHuman Molecular Genetics, 1994
- Identification of the primary gene defect at the cytochrome P450 CYP2D locusNature, 1990